{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:59:07Z","timestamp":1780113547219,"version":"3.54.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While most pulmonary infections with Coccidioides spp. are self-limited, a subset of patients is at higher risk for severe disease and extrapulmonary dissemination, including individuals with certain ethnic backgrounds. Disseminated disease can involve soft tissues, bones, and the central nervous system with high morbidity and mortality in the absence of antifungal treatment. Diagnosis of coccidioidomycosis can be challenged by the availability of specimens for culture or histopathology, confusion with, or lack of availability of various antibody tests and overall lack of consideration of Coccidioides spp. as the etiology of disease, especially in immunocompetent hosts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We set out to characterize cases of disseminated coccidioidomycosis at our institution over a 7-year period, solely in immunocompetent hosts, to highlight diagnostic delays and determine which, if any, primary screening test might be the most useful.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 40 cases met our inclusion criteria, and 100% of these cases had positive immunoglobulin G antibodies on a US FDA-cleared Coccidioides spp. enzyme immunoassay. Nearly all of the cases (87%) had a delay in diagnosis and associated worsening of disease (71%). Locations of initial presentations that led to delayed recognition included primary care settings (56%), emergency departments (33%), and urgent care centers (11%), all in the region of Coccidioides spp. endemicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings highlight the need for interventions to increase awareness of the risk factors for, the symptoms of, and the appropriate testing options to diagnose disseminated coccidioidomycosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvaf187","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T12:55:45Z","timestamp":1765630545000},"page":"575-582","source":"Crossref","is-referenced-by-count":1,"title":["Disseminated Coccidioidomycosis in Immunocompetent Hosts: Opportunities for Increased Recognition and Timely Diagnosis"],"prefix":"10.1093","volume":"72","author":[{"given":"Anna C H","family":"Hoge","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Phoenix, AZ ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-124X","authenticated-orcid":false,"given":"Thomas E","family":"Grys","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Phoenix, AZ ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6014-4570","authenticated-orcid":false,"given":"Erin H","family":"Graf","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Phoenix, AZ ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"2026050508172157200_hvaf187-B1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1029\/2019GH000209","article-title":"Expansion of coccidioidomycosis endemic regions in the United States in response to climate change","volume":"3","author":"Gorris","year":"2019","journal-title":"Geohealth"},{"key":"2026050508172157200_hvaf187-B2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3201\/eid1407.070832","article-title":"Testing for coccidioidomycosis among patients with community-acquired pneumonia","volume":"14","author":"Chang","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"2026050508172157200_hvaf187-B3","doi-asserted-by":"crossref","first-page":"ofae461","DOI":"10.1093\/ofid\/ofae461","article-title":"Improving coccidioidomycosis testing for emergency department patients with suspect community-acquired pneumonia: analysis of provider attitudes and the effect of a targeted intervention","volume":"11","author":"Cunningham","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026050508172157200_hvaf187-B4","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026050508172157200_hvaf187-B5","doi-asserted-by":"crossref","first-page":"e3814","DOI":"10.1093\/cid\/ciaa1154","article-title":"Natural history of disseminated coccidioidomycosis: examination of the veterans affairs-armed forces database","volume":"73","author":"Bays","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026050508172157200_hvaf187-B6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3201\/eid2302.160505","article-title":"Risk factors for disseminated coccidioidomycosis, United States","volume":"23","author":"Odio","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2026050508172157200_hvaf187-B7","doi-asserted-by":"crossref","first-page":"myaf004","DOI":"10.1093\/mmy\/myaf004","article-title":"The profound effect of diabetes mellitus control on outcomes of coccidioidomycosis","volume":"63","author":"El Kurdi","year":"2025","journal-title":"Med Mycol"},{"key":"2026050508172157200_hvaf187-B8","doi-asserted-by":"crossref","first-page":"e159491","DOI":"10.1172\/jci.insight.159491","article-title":"Immunogenetics associated with severe coccidioidomycosis","volume":"7","author":"Hsu","year":"2022","journal-title":"JCI Insight"},{"key":"2026050508172157200_hvaf187-B9","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3201\/eid2508.190019","article-title":"Delays in coccidioidomycosis diagnosis and relationship to healthcare utilization, Phoenix, Arizona, USA(1)","volume":"25","author":"Ginn","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2026050508172157200_hvaf187-B10","doi-asserted-by":"crossref","first-page":"ofae041","DOI":"10.1093\/ofid\/ofae041","article-title":"Challenges facing antimicrobial stewardship programs in the endemic region for coccidioidomycosis","volume":"11","author":"Hayes","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026050508172157200_hvaf187-B11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/jof11020161","article-title":"The burden of hospital illness associated with disseminated versus isolated pulmonary coccidioidomycosis in the United States","volume":"11","author":"Coleman","year":"2025","journal-title":"J Fungi (Basel)"},{"key":"2026050508172157200_hvaf187-B12","doi-asserted-by":"crossref","first-page":"ofae706","DOI":"10.1093\/ofid\/ofae706","article-title":"Burden of hospitalization for coccidioidal meningitis: an analysis of the national inpatient sample, 2019\u20132021","volume":"11","author":"Coleman","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026050508172157200_hvaf187-B13","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.cmi.2025.02.001","article-title":"Antifungal therapy patterns, healthcare utilization, costs, and mortality in central nervous system and non-central nervous system disseminated coccidioidomycosis across the continuum-of-care","volume":"31","author":"Donovan","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"2026050508172157200_hvaf187-B14","first-page":"33","article-title":"Coccidioidomycosis: the other great imitator","volume":"56","author":"Cardone","year":"1995","journal-title":"Cutis"},{"key":"2026050508172157200_hvaf187-B15","doi-asserted-by":"crossref","first-page":"ofac654","DOI":"10.1093\/ofid\/ofac654","article-title":"Improving early recognition of coccidioidomycosis in urgent care clinics: analysis of an implemented education program","volume":"10","author":"Pu","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026050508172157200_hvaf187-B16","doi-asserted-by":"crossref","first-page":"e0158122","DOI":"10.1128\/jcm.01581-22","article-title":"Review of clinical and laboratory diagnostics for coccidioidomycosis","volume":"61","author":"McHardy","year":"3","journal-title":"J Clin Microbiol"},{"key":"2026050508172157200_hvaf187-B17","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/mmy\/myy019","article-title":"Coccidioidomycosis in selected immunosuppressed hosts","volume":"57","author":"Blair","year":"2019","journal-title":"Med Mycol"},{"key":"2026050508172157200_hvaf187-B18","doi-asserted-by":"crossref","first-page":"ofaa167","DOI":"10.1093\/ofid\/ofaa167","article-title":"Coccidioidomycosis in patients treated with ruxolitinib","volume":"7","author":"Kusne","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2026050508172157200_hvaf187-B19","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026050508172157200_hvaf187-B20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/JCM.01776-06","article-title":"Detection of coccidioides species in clinical specimens by real-time PCR","volume":"45","author":"Binnicker","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2026050508172157200_hvaf187-B21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccm.2017.04.013","article-title":"Laboratory diagnostics for fungal infections: a review of current and future diagnostic assays","volume":"38","author":"Ramanan","year":"2017","journal-title":"Clin Chest Med"},{"key":"2026050508172157200_hvaf187-B22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/mmy\/myy094","article-title":"Comparison of two FDA-cleared EIA assays for the detection of Coccidioides antibodies against a composite clinical standard","volume":"57","author":"Grys","year":"2019","journal-title":"Med Mycol"},{"key":"2026050508172157200_hvaf187-B23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/JCM.01318-18","article-title":"Coccidioidomycosis complement fixation titer trends in the age of antifungals","volume":"56","author":"McHardy","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2026050508172157200_hvaf187-B24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.3.3.247","article-title":"Serology of coccidioidomycosis","volume":"3","author":"Pappagianis","year":"1990","journal-title":"Clin Microbiol Rev"},{"key":"2026050508172157200_hvaf187-B25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jama.1956.02960420026008","article-title":"Pattern of 39,500 serologic tests in coccidioidomycosis","volume":"160","author":"Smith","year":"1956","journal-title":"J Am Med Assoc"},{"key":"2026050508172157200_hvaf187-B26","doi-asserted-by":"crossref","first-page":"e00052-25","DOI":"10.1128\/asmcr.00052-25","article-title":"When should coccidioidomycosis be in the differential?","volume":"1","author":"Galgiani","year":"2025","journal-title":"ASM Case Rep"},{"key":"2026050508172157200_hvaf187-B27","doi-asserted-by":"crossref","first-page":"e2746","DOI":"10.1093\/cid\/ciaa1205","article-title":"Comparison of a novel rapid lateral flow assay to enzyme immunoassay results for early diagnosis of coccidioidomycosis","volume":"73","author":"Donovan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026050508172157200_hvaf187-B28","doi-asserted-by":"crossref","first-page":"e0062323","DOI":"10.1128\/jcm.00623-23","article-title":"Investigation of discordant positive sona lateral flow assay results for detection of coccidioides antibodies","volume":"61","author":"Lu","year":"2023","journal-title":"J Clin Microbiol"},{"key":"2026050508172157200_hvaf187-B29","author":"Contreras"},{"key":"2026050508172157200_hvaf187-B30","doi-asserted-by":"crossref","first-page":"e0063123","DOI":"10.1128\/jcm.00631-23","article-title":"Development of a rapid lateral flow assay for detection of anti-coccidioidal antibodies","volume":"61","author":"Grill","year":"2023","journal-title":"J Clin Microbiol"},{"key":"2026050508172157200_hvaf187-B31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/jof6030125","article-title":"Comparative study of newer and established methods of diagnosing coccidioidal meningitis","volume":"6","author":"Stevens","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2026050508172157200_hvaf187-B32","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/JCM.01843-09","article-title":"False-positive IgM serology in coccidioidomycosis","volume":"48","author":"Kuberski","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2026050508172157200_hvaf187-B33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/CVI.00531-12","article-title":"Clinical specificity of the enzyme immunoassay test for coccidioidomycosis varies according to the reason for its performance","volume":"20","author":"Blair","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"2026050508172157200_hvaf187-B34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/1475-6773.14202","article-title":"Eliminating health care inequities through strengthening access to care","volume":"58","author":"Jindal","year":"2023","journal-title":"Health Serv Res"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/5\/575\/66611444\/hvaf187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/5\/575\/66611444\/hvaf187.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:17:33Z","timestamp":1777983453000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/72\/5\/575\/8443197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,1,28]]},"published-print":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvaf187","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,1,28]]}}}